NCYT
NEUTRALNovacyt Outlines Growth Strategy and Investor Presentation
The healthcare company announces a strategy update and plans to host an investor presentation, providing an outlook for FY25 and outlining its organic financial goals.
Novacyt S.A.
39.80GBX
-0.50%
Market Cap
28.11M
Volume
14.41k
23% of avg
P/E Ratio
NaN
EPS (TTM)
Beta
1.11
Day Range
39.00p - 41.00p
52 Week Range
36.00p39.80p69.00p
39.80p
Upcoming Events
Q1 2026
Launch of enhanced DPYD product assay
High Impact Event
NCYT
NEUTRALNovacyt Reports Reduced Losses in H1 2025 Interim Results
The molecular diagnostics company reported reduced losses and modest revenue growth in H1 2025. Despite cash burn, management believes there's sufficient funding to reach EBITDA profitability.
NCYT
NEUTRALNovacyt Announces Notice of Results
The healthcare company has announced it will report its unaudited interim results for the first half of 2025 on 30 September 2025.
NCYT
NEUTRALNovacyt Appoints Singer Capital Markets as Joint Corporate Broker
The healthcare company has appointed Singer Capital Markets as a joint corporate broker, working alongside its existing broker SP Angel.
NCYT
NEUTRALNovacyt Resolves Lab 21 HSE Prosecution
The healthcare company has resolved a legal prosecution against one of its subsidiaries, with the subsidiary pleading guilty and receiving a fine.
NCYT
NEUTRALNovacyt Reports Mixed H1 2025 Trading Update
The healthcare company reports mixed H1 2025 trading, with underlying revenue growth offset by a slight statutory revenue decline. The firm remains focused on executing growth to reach profitability.
NCYT
NEUTRALNovacyt Launches New LightBench® Discover Instrument
The healthcare company has launched a new high-precision 3-in-1 instrument for genomic research labs conducting long-read sequencing.
NCYT
NEUTRALNovacyt Publishes Annual Report
The healthcare company has published its annual report for the year ended 31 December 2024.
NCYT
NEUTRALNovacyt Announces AGM Voting Details
The healthcare company provides details on the upcoming Annual General Meeting, including instructions for shareholders to vote in advance.
NCYT
NEUTRALNovacyt Announces Notice of Annual General Meeting
The healthcare company has announced the date and details for its upcoming Annual General Meeting.